Company Profiles

driven by the PitchBook Platform

MicuRx Pharmaceuticals

Description

Developer of drugs and antibiotics intended to be used for treating drug-resistant bacterial infections. The company's drugs and antibiotics are targeted to treat Multi-drug resistant (MDR) infections which represent a major global threat to the public health, enabling patients and healthcare institutions to avail safer and more convenient antibiotics to combat drug-resistant bacterial infections.

2007

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$55M

Latest Deal Amount

$92M

Total Amount Raised

Description

Developer of drugs and antibiotics intended to be used for treating drug-resistant bacterial infections. The company's drugs and antibiotics are targeted to treat Multi-drug resistant (MDR) infections which represent a major global threat to the public health, enabling patients and healthcare institutions to avail safer and more convenient antibiotics to combat drug-resistant bacterial infections.

Website:

www.micurx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Biotechnology

Primary Office

3916 Trust Way Hayward, CA 94545United States +1 (510) 782-2021
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore MicuRx Pharmaceuticals's full profile, request a free trial.

    MicuRx Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    MicuRx Pharmaceuticals Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    3E Bioventures CapitalVenture CapitalMinority000 0000000 0000
    BVCFGrowth/ExpansionMinority000 0000000 0000
    Delin CapitalGrowth/ExpansionMinority000 0000000 0000
    Devon Park BioventuresVenture CapitalMinority000 0000000 0000
    GP Healthcare CapitalVenture CapitalMinority000 0000000 0000
    3E Bioventures Capital Venture Capital
    BVCF Growth/Expansion
    Delin Capital Growth/Expansion
    Devon Park Bioventures Venture Capital
    GP Healthcare Capital Venture Capital

    MicuRx Pharmaceuticals Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Zhengyu Yuan Ph.DCo-Founder, President, Chief Executive Officer & Board Member
    Mike Gordeev Ph.DChief Scientific Officer & Co-Founder
    Leisa DennehyCommercial & Corporate Development Advisor
    Barry Hafkin MDChief Medical Officer
    Zhengyu Yuan Ph.D Co-Founder, President, Chief Executive Officer & Board Member
    Mike Gordeev Ph.D Chief Scientific Officer & Co-Founder
    Leisa Dennehy Commercial & Corporate Development Advisor
    Barry Hafkin MD Chief Medical Officer

    MicuRx Pharmaceuticals Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Davis YangBVCFDirector000 0000
    George ChangMorningside GroupManaging Director000 0000
    Lu Huang MDMorningside GroupManaging Director000 0000
    Weixin YuBVCFBoard Member000 0000
    Yu MiaoGP Healthcare CapitalExecutive000 0000
    Davis Yang Director BVCF
    George Chang Managing Director Morningside Group
    Lu Huang MD Managing Director Morningside Group
    Weixin Yu Board Member BVCF
    Yu Miao Executive GP Healthcare Capital
    Request full access to PitchBook